Hugo Peris

Company: Spiral Therapeutics

Job title: Chief Executive Officer

Seminars:

Ensuring Desired Target Exposure in the Cochlea with Novel Sustained Release Drug Formulations for Reduced Injection Frequency & Improved Patient Compliance 1:30 pm

Utilizing targeted delivery systems such as nanoparticle-based carriers and intra-tympanic injections for localized delivery to ensure minimal systemic exposure and maximum therapeutic efficacy Developing slow-release drug formulations to improve their ability to penetrate barriers within the inner ear, ensuring optimal target exposure Optimizing drug dosage to achieve desired target exposure levels by utilizing pharmacokinetic modelling…Read more

day: Conference Day 2